Blessing Bassey-Archibong

Has grant

Assistant Professor

Concordia University of Edmonton
Country flagCanada

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Role of HLA-G and SPAG9 in the Normal Brain

Open Date: 2025-01-01

Close Date: 2026-01-01

Grant: Close

Elucidating the roles of Kaiso in TNBC racial disparity in women of African ancestry

Open Date: 2013-01-01

Close Date: 2016-01-01

Articles (5)

Brain metastasis occurs in up to 40% of patients with non–small cell lung cancer (NSCLC). Considerable genomic heterogeneity exists between the primary lung tumor and respective brain metastasis; however, the identity of the genes capable of driving brain metastasis is incompletely understood. Here, we carried out an in vivo genome-wide CRISPR activation screen to identify molecular drivers of brain metastasis from an orthotopic xenograft model derived from a patient with NSCLC. We found that activating expression of the Alzheimer’s disease–associated beta-secretase 1 (BACE1) led to a substantial increase in brain metastases. Furthermore, genetic and pharmacological inhibition of BACE1 blocked NSCLC brain metastasis. Mechanistically, we identified that BACE1 acts through epidermal growth factor receptor to drive this metastatic phenotype. Together, our data highlight the power of in vivo CRISPR activation screening to unveil molecular drivers and potential therapeutic targets of NSCLC brain metastasis.

Year:

2025

The six most common missense mutations in the DNA binding domain of p53 are known as “hot spots” and include two of the most frequently occurring p53 mutations (p53-R175H and p53-R273H). p53 stability and function are regulated by various post-translational modifications such as phosphorylation, acetylation, sumoylation, methylation, and interactions with other proteins including plakoglobin. Previously, using various carcinoma cell lines we showed that plakoglobin interacted with wild-type and several endogenous p53 mutants (e.g., R280K, R273H, S241F, S215R, R175H) and restored their tumor suppressor activities in vitro . Since mutant p53 function is both mutant-specific and cell context-dependent, we sought herein, to determine if plakoglobin tumor suppressive effects on exogenously expressed p53-R273H and p53-R175H mutants are similarly maintained under the same genetic background using the p53-null and plakoglobin-deficient H1299 cell line. Functional assays were performed to assess colony formation, migration, and invasion while immunoblotting and qPCR were used to examine the subcellular distribution and expression of specific proteins and genes that are typically regulated by or regulate p53 function and are altered in mutant p53-expressing cell lines and tumors. We show that though, plakoglobin interacted with both p53-R273H and p53-R175H mutants, it had a differential effect on the transcription and subcellular distribution of their gene targets and their overall oncogenic properties in vitro . Notably, we found that plakoglobin’s tumor suppressive effects were significantly stronger in p53-R175H expressing cells compared to p53-R273H cells. Together, our results indicate that exploring plakoglobin interactions with p53-R175H may be useful for the development of cancer therapeutics focused on the restoration of p53 function.

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (15)

Jongmyung Kim

Assistant Professor

University of South Florida

UNITED STATES
View details

Qi Zhang

University of Western Ontario

CANADA
View details

Patrick Derksen

PRINCIPAL INVESTIGATOR/PROFESSOR, PHD

Universitair Medisch Centrum Utrecht

NETHERLANDS
View details

Sheila K. Singh

McMaster University

CANADA
View details

Charles Swanton

Chief Clinician

-

UNITED KINGDOM
View details

Christine Desmedt

Head of Laboratory for Translational Breast Cancer Research

KU Leuven

BELGIUM
View details

Thijs Koorman

Assistant Professor

Universitair Medisch Centrum Utrecht

NETHERLANDS
View details

Jason Moffat

Senior Scientist and Program Head

Hospital for Sick Children

CANADA
View details

Ariana Huebner

University College London

UNITED KINGDOM
View details

Jian‐Qiang Lu

Neuropathologist

McMaster University Faculty of Health Sciences

CANADA
View details

Kui Zhai

McMaster University

CANADA
View details

Shawn Li

Professor

Western University

CANADA
View details

Antoine Dufour

Professor

University of Calgary

CANADA
View details

James K. C. Liu

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES
View details

Shawn Chafe

Research Associate

McMaster University

CANADA
View details